Singapore, Aug. 4 -- Scientists have launched the first-ever library of adjuvants - substances that could boost the performance of vaccines tackling some of the world's deadliest diseases.

The UK's Medicines and Healthcare products Regulatory Agency (MHRA) will host a repository of 25 vaccine-enhancing adjuvants that can be 'taken off the shelf' and used in new vaccines being developed against epidemic and pandemic threats. This includes diseases like mpox, COVID-19 and Ebola, as well as a novel or as-yet-unidentified Disease X.

The $2.5 million project-funded and led by Norway-based Coalition for Epidemic Preparedness Innovations (CEPI)-will act as a matchmaking service, helping vaccine developers select the best vaccine-adjuvant combi...